SCHEMBL29957602

SCHEMBL29957602

COCCOc1nc(Br)cc(NCc2cn3cc(C4CC4)ccc3n2)n1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 1/20 0.41
▸ KLKB1 P03952 19/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27033838 1.00 METTL3 (0.41) METTL3KLKB1
SCHEMBL24729470 0.79 METTL3 (0.44) METTL3KLKB1
SCHEMBL29927129 0.79 METTL3 (0.44) METTL3KLKB1
SCHEMBL30997805 0.78 METTL3 (0.42) METTL3KLKB1
SCHEMBL24739081 0.78 METTL3 (0.42) METTL3KLKB1
SCHEMBL30997753 0.77 METTL3 (0.42) METTL3KLKB1
SCHEMBL24738215 0.77 METTL3 (0.42) METTL3KLKB1
SCHEMBL27033751 0.76 KLKB1 (0.56) KLKB1
SCHEMBL29305304 0.76 METTL3 (0.42) METTL3KLKB1
SCHEMBL24729486 0.75 METTL3 (0.42) METTL3KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308228-A1 PLASMA KALLIKREIN INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
CN-117396474-A Plasma kallikrein inhibitors 武田药品工业株式会社 2024-01-12 — — CN disclosed
WO-2022197756-A1 PLASMA KALLIKREIN INHIBITORS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback